Tirzepatide is a novel dual GIP and GLP-1 receptor agonist that has shown promising results in metabolic research. This synthetic peptide consists of 39 amino acids and is structurally similar to the endogenous incretin hormones.
Our research-grade Tirzepatide comes in lyophilized white powder form with purity exceeding 99% as verified by HPLC analysis. Each vial contains precisely measured doses of 2mg, 5mg, 10mg, 15mg or 20mg for accurate research applications.
The peptide is supplied in sterile vials (10 vials per box) with proper labeling and batch documentation. For optimal stability, store in a cool, dry place at temperatures between 2-8°C. The product maintains stability for 24 months when stored properly.
This product is intended for research purposes only in laboratory settings. It is not for human consumption or diagnostic use. Researchers should handle all peptides with proper laboratory safety protocols.
Key research applications include metabolic studies, glucose regulation research, and weight management investigations. The dual agonist properties make it particularly interesting for comparative studies with single-receptor agonists.